AlphaYouDB
Congress trade
Rep. Donald Beyer (D-VA) bought $1K-$15K of Editas Medicine, Inc. (EDIT) stock
Donald Beyer, U.S. Representative (D-VA), disclosed a purchase of Editas Medicine, Inc. (EDIT) stock worth $1K-$15K in a STOCK Act filing on Dec 14, 2019.
The trade happened on Nov 22, 2019, 22 days before it was made public.
EDIT has moved -89.2% since the trade date, from $24.36 to $2.62 (Oct 2, 2026 close).
- Traded
- Nov 22, 2019
- Disclosed
- Dec 14, 2019
- Filing delay
- 22 days
- Price since
- -89.2%
- Source
- STOCK Act disclosure
Other trades in this disclosure (60)
- BuyAAPL$1K-$15KDec 14, 2019
- BuyAAPL$1K-$15KDec 14, 2019
- BuyAAPL$1K-$15KDec 14, 2019
- BuyAAPL$1K-$15KDec 14, 2019
- BuyACN$1K-$15KDec 14, 2019
- BuyACN$1K-$15KDec 14, 2019
- BuyACN$1K-$15KDec 14, 2019
- BuyAMZN$1K-$15KDec 14, 2019
- BuyAMZN$1K-$15KDec 14, 2019
- BuyBRK.B$1K-$15KDec 14, 2019
- BuyBRK.B$1K-$15KDec 14, 2019
- BuyC$1K-$15KDec 14, 2019
- BuyC$1K-$15KDec 14, 2019
- BuyC$1K-$15KDec 14, 2019
- BuyCYRX$1K-$15KDec 14, 2019
- BuyCYRX$1K-$15KDec 14, 2019
- BuyDAIUF$1K-$15KDec 14, 2019
- BuyDAIUF$1K-$15KDec 14, 2019
- BuyDAIUF$1K-$15KDec 14, 2019
- BuyDAIUF$1K-$15KDec 14, 2019
More EDIT insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.